Huaimin Liu

1.7k total citations · 1 hit paper
42 papers, 794 citations indexed

About

Huaimin Liu is a scholar working on Oncology, Nuclear and High Energy Physics and Molecular Biology. According to data from OpenAlex, Huaimin Liu has authored 42 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Nuclear and High Energy Physics and 10 papers in Molecular Biology. Recurrent topics in Huaimin Liu's work include Particle physics theoretical and experimental studies (10 papers), Particle Detector Development and Performance (10 papers) and High-Energy Particle Collisions Research (5 papers). Huaimin Liu is often cited by papers focused on Particle physics theoretical and experimental studies (10 papers), Particle Detector Development and Performance (10 papers) and High-Energy Particle Collisions Research (5 papers). Huaimin Liu collaborates with scholars based in China, United States and Italy. Huaimin Liu's co-authors include Xiaoli Liu, Liang Geng, Yun Cui, Fuming Zhang, Suxia Luo, Qingfeng Jiang, Jia Li, Xiaona Meng, Yanhui Hu and Qilong Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Immunological Reviews.

In The Last Decade

Huaimin Liu

36 papers receiving 784 citations

Hit Papers

PANoptosis: Mechanisms, b... 2023 2026 2024 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaimin Liu China 12 478 254 113 84 74 42 794
Karim Chahed Tunisia 21 416 0.9× 188 0.7× 137 1.2× 109 1.3× 107 1.4× 50 883
Jiao Li China 16 392 0.8× 132 0.5× 107 0.9× 68 0.8× 63 0.9× 31 686
Azhar Ali Singapore 16 635 1.3× 383 1.5× 131 1.2× 107 1.3× 54 0.7× 33 1.2k
Ramadevi Subramani United States 21 631 1.3× 372 1.5× 303 2.7× 75 0.9× 59 0.8× 32 1.0k
Liyan Ji China 15 332 0.7× 104 0.4× 143 1.3× 75 0.9× 49 0.7× 30 644
Sichun Zhou China 13 382 0.8× 175 0.7× 96 0.8× 62 0.7× 68 0.9× 20 596
Amr Ahmed El‐Arabey Egypt 13 436 0.9× 234 0.9× 124 1.1× 65 0.8× 152 2.1× 41 811
Shaomi Zhu China 14 370 0.8× 163 0.6× 83 0.7× 56 0.7× 112 1.5× 27 687
Xiaodan Sun China 14 304 0.6× 121 0.5× 113 1.0× 62 0.7× 62 0.8× 39 556
Chuanxu Liu China 12 470 1.0× 112 0.4× 84 0.7× 60 0.7× 96 1.3× 30 776

Countries citing papers authored by Huaimin Liu

Since Specialization
Citations

This map shows the geographic impact of Huaimin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaimin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaimin Liu more than expected).

Fields of papers citing papers by Huaimin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaimin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaimin Liu. The network helps show where Huaimin Liu may publish in the future.

Co-authorship network of co-authors of Huaimin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Huaimin Liu. A scholar is included among the top collaborators of Huaimin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaimin Liu. Huaimin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Fang & Huaimin Liu. (2025). RE: Long-term survival across Breslow thickness categories: findings from a population-based study of 210 042 Australian melanoma patients. JNCI Journal of the National Cancer Institute. 117(5). 1080–1081.
2.
Sun, Xu, Yongqiu Zheng, Huahua Li, et al.. (2023). Astragalus polysaccharide alleviates alcoholic-induced hepatic fibrosis by inhibiting polymerase I and transcript release factor and the TLR4/JNK/NF-κB/MyD88 pathway. Journal of Ethnopharmacology. 314. 116662–116662. 50 indexed citations
3.
Liu, Huaimin, et al.. (2023). The Relationship between Golgi Protein 73, Alpha-Fetoprotein, Liver Function Indicators, and Traditional Chinese Medicine Syndrome Types of Primary Liver Cancer. SHILAP Revista de lepidopterología. 3(4). e165–e171. 1 indexed citations
4.
Zhang, Lu, Qing Ji, Zhenzhen Wei, et al.. (2023). Akkermansia muciniphila inhibits tryptophan metabolism via the AhR/β-catenin signaling pathway to counter the progression of colorectal cancer. International Journal of Biological Sciences. 19(14). 4393–4410. 41 indexed citations
5.
Meng, Xiaona, et al.. (2023). PANoptosis: Mechanisms, biology, and role in disease. Immunological Reviews. 321(1). 246–262. 133 indexed citations breakdown →
6.
Zhang, Lihan, Xing Li, Lihao Guo, et al.. (2023). Nanodrugs systems for therapy and diagnosis of esophageal cancer. Frontiers in Bioengineering and Biotechnology. 11. 1233476–1233476. 9 indexed citations
7.
Hu, Yanhui, et al.. (2022). Anlotinib in recurrent or metastatic endometrial cancer. International Journal of Gynecological Cancer. 32(9). 1147–1152. 4 indexed citations
8.
Zhang, Jiawei, L. H. Wu, S. S. Sun, et al.. (2022). Suppression of top-up injection backgrounds with offline event filter in the BESIII experiment. Radiation Detection Technology and Methods. 6(3). 289–293. 2 indexed citations
9.
Hu, Yanhui, et al.. (2022). Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance. Frontiers in Pharmacology. 12. 746707–746707. 13 indexed citations
10.
Hu, Yanhui, et al.. (2021). A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer. Drug Design Development and Therapy. Volume 15. 339–347. 20 indexed citations
11.
Li, Jia, Huahua Li, Chenyue Zhang, et al.. (2021). Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma. Frontiers in Oncology. 11. 732841–732841. 2 indexed citations
12.
Sun, Xu, et al.. (2021). Relationship between HLA-DRB1 gene polymorphism and breast cancer. Medicine. 100(12). e25078–e25078. 5 indexed citations
13.
Que, Zujun, Yun Yang, Haitao Liu, et al.. (2020). Jinfukang regulates integrin/Src pathway and anoikis mediating circulating lung cancer cells migration. Journal of Ethnopharmacology. 267. 113473–113473. 27 indexed citations
14.
15.
Liu, Xiaoli, Huaimin Liu, & Suxia Luo. (2018). Reversal of resistance to chemotherapy following anti-programmed cell death-1 immunotherapy in metastatic lung adenocarcinoma. Medicine. 97(49). e13427–e13427. 1 indexed citations
16.
Liu, Huanhuan, S. S. Sun, S. S. Fang, et al.. (2017). A study of aging effects of barrel Time-Of-Flight system in the BESIII experiment. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 882. 41–44. 3 indexed citations
17.
Gao, Qilong, Huaimin Liu, Yamin Yao, et al.. (2014). Carnosic acid induces autophagic cell death through inhibition of the Akt/mTOR pathway in human hepatoma cells. Journal of Applied Toxicology. 35(5). 485–492. 47 indexed citations
18.
Zhang, Rui, D. Xiao, F. F. An, et al.. (2014). Improvement of main drift chamber Monte-Carlo tuning model at BESIII. Chinese Physics C. 38(2). 26201–26201.
19.
Liang, Y. T., Bo Zhu, Z. You, et al.. (2009). A uniform geometry description for simulation, reconstruction and visualization in the BESIII experiment. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 603(3). 325–327. 7 indexed citations
20.
Lü, Mei, et al.. (2007). [Multi-central clinical evaluation of ginger-partitioned moxibustion for treatment of leukopenia induced by chemotherapy].. PubMed. 27(10). 715–20. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026